Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
TrimRx offers consultations with licensed providers and compounded semaglutide at $199/month, making treatment accessible and sustainable
Of note, a small number of cases of acute pancreatitis associated with GLP-1RA use have been reported in clinical trials: 38 cases in 17,775 patient-years of exposure compared with 9 events in 5863 patient-years of exposure with the comparator treatment
The FDA has not approved BPC-157 for clinical use
The risk of reduced potency or contamination is not worth the savings from squeezing out a few extra doses
Tirzepatide, a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) helps in weight loss, but its effects on cardiovascular outcomes are unclear
US$ 23.76
US$ 21.45
US$ 28.36
US$ 28.41
